{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:44:50Z","timestamp":1792773890841,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bj.2026.101057","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:07:13Z","timestamp":1792685233000},"page":"101057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Ionophores to Tackle Antimicrobial Resistance with a Focus on PBT2"],"prefix":"10.1016","author":[{"given":"Huiting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-7396","authenticated-orcid":false,"given":"Freda E.-C.","family":"Jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10459","key":"10.1016\/j.bj.2026.101057_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: A systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2026.101057_bib2","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: Final report and recommendations. London: Review on Antimicrobial Resistance, HM Government and Wellcome Trust; 2016."},{"issue":"6554","key":"10.1016\/j.bj.2026.101057_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.abl5997","article-title":"The post-antibiotic era is here","volume":"373","author":"Kwon","year":"2021","journal-title":"Science"},{"issue":"49","key":"10.1016\/j.bj.2026.101057_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016-2023 and future projections through 2030","volume":"121","author":"Klein","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2026.101057_bib5","unstructured":"WHO. Global antibiotic resistance surveillance report 2025: Global antimicrobial resistance and use surveillance system (GLASS). Geneva: World Health Organization; 2025."},{"issue":"8016","key":"10.1016\/j.bj.2026.101057_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07502-0","article-title":"A Gram-negative-selective antibiotic that spares the gut microbiome","volume":"630","author":"Munoz","year":"2024","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.bj.2026.101057_bib7","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1039\/C7MD00528H","article-title":"Narrow-spectrum antibacterial agents","volume":"9","author":"Melander","year":"2018","journal-title":"Medchemcomm"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.bj.2026.101057_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bj.2026.101057_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111661","article-title":"The antimicrobial and immunomodulatory effects of ionophores for the treatment of human infection","volume":"227","author":"Li","year":"2022","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bj.2026.101057_bib12","doi-asserted-by":"crossref","unstructured":"Littmann J, Viens AM, Silva DS. The super-wicked problem of antimicrobial resistance. In: Jamrozik E, Selgelid M, editors. Ethics and drug resistance: Collective responsibility for global public health. Cham: Springer International Publishing; 2020, p. 421\u2013443.","DOI":"10.1007\/978-3-030-27874-8_26"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s44259-025-00096-1","article-title":"Antibiotics re-booted-time to kick back against drug resistance","volume":"3","author":"Blaskovich","year":"2025","journal-title":"NPJ Antimicrob Resist"},{"key":"10.1016\/j.bj.2026.101057_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.bi.45.070176.002441","article-title":"Biological applications of ionophores","volume":"45","author":"Pressman","year":"1976","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"10.1016\/j.bj.2026.101057_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02391-18","article-title":"Chemical synergy between ionophore PBT2 and zinc reverses antibiotic resistance","volume":"9","author":"Bohlmann","year":"2018","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110202","article-title":"Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model","volume":"38","author":"Brazel","year":"2022","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.bj.2026.101057_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01229-26","article-title":"Ionophore PBT2 as a novel approach to combat antibiotic-resistant Helicobacter pylori","volume":"17","author":"Chen","year":"2026","journal-title":"mBio"},{"issue":"570","key":"10.1016\/j.bj.2026.101057_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3791","article-title":"Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis","volume":"12","author":"De Oliveira","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib19","doi-asserted-by":"crossref","first-page":"e03517","DOI":"10.1128\/mbio.03517-21","article-title":"Rescuing tetracycline class antibiotics for the treatment of multidrug-resistant Acinetobacter baumannii pulmonary infection","volume":"13","author":"De Oliveira","year":"2022","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/antibiotics11040449","article-title":"Neurodegenerative disease treatment drug PBT2 breaks intrinsic polymyxin resistance in Gram-positive bacteria","volume":"11","author":"De Oliveira","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.15698\/mic2022.03.772","article-title":"An ionophore breaks the multi-drug-resistance of Acinetobacter baumannii","volume":"9","author":"De Oliveira","year":"2022","journal-title":"Microb Cell"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00157-20","article-title":"Multiple bactericidal mechanisms of the zinc ionophore PBT2","volume":"5","author":"Harbison-Price","year":"2020","journal-title":"mSphere"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02318-21","article-title":"Repurposing the ionophore, PBT2, for treatment of multidrug-resistant Neisseria gonorrhoeae infections","volume":"66","author":"Jen","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.bj.2026.101057_bib24","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/jac\/dkab291","article-title":"A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides","volume":"76","author":"Jen","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/acsinfecdis.9b00307","article-title":"Neisseria gonorrhoeae becomes susceptible to polymyxin b and colistin in the presence of PBT2","volume":"6","author":"Jen","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"8","key":"10.1016\/j.bj.2026.101057_bib26","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1021\/acsinfecdis.0c00887","article-title":"Disruption of metallostasis in the anaerobic human pathogen Fusobacterium nucleatum by the zinc ionophore PBT2","volume":"7","author":"Van Zuylen","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bj.2026.101057_bib27","article-title":"Disruption of zinc homeostasis reverses tigecycline resistance in Klebsiella pneumoniae","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial A\u03b2","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.bj.2026.101057_bib30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.trci.2017.10.001","article-title":"A randomized, exploratory molecular imaging study targeting amyloid beta with a novel 8-oh quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study","volume":"3","author":"Villemagne","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1474-4422(14)70262-5","article-title":"Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial","volume":"14","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bj.2026.101057_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0065-2164(08)70163-1","article-title":"Polyether antibiotics: Versatile carboxylic acid ionophores produced by Streptomyces","volume":"22","author":"Westley","year":"1977","journal-title":"Adv Appl Microbiol"},{"issue":"19","key":"10.1016\/j.bj.2026.101057_bib34","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1039\/C5DT00634A","article-title":"Pharmacological activity of metal binding agents that alter copper bioavailability","volume":"44","author":"Helsel","year":"2015","journal-title":"Dalton Trans"},{"issue":"11","key":"10.1016\/j.bj.2026.101057_bib35","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1021\/ja01155a084","article-title":"The isolation of three new crystalline antibiotics from Streptomyces","volume":"73","author":"Berger","year":"1951","journal-title":"J Am Chem Soc"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib36","first-page":"594","article-title":"Nigericin a new crystalline antibiotic from an unidentified Streptomyces","volume":"1","author":"Harned","year":"1951","journal-title":"Antibiot Chemother (Northfield)"},{"issue":"5","key":"10.1016\/j.bj.2026.101057_bib37","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1073\/pnas.58.5.1949","article-title":"Antibiotic-mediated transport of alkali ions across lipid barriers","volume":"58","author":"Pressman","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: An overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1057\/s41599-018-0152-2","article-title":"Pharming animals: A global history of antibiotics in food production (1935\u20132017)","volume":"4","author":"Kirchhelle","year":"2018","journal-title":"Palgrave Communications"},{"key":"10.1016\/j.bj.2026.101057_bib40","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.3168\/jds.S0022-0302(01)70218-4","article-title":"Ionophores for dairy cattle: Current status and future outlook","volume":"84","author":"McGuffey","year":"2001","journal-title":"J Dairy Sci"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.taap.2010.12.014","article-title":"Risk assessment of coccidostatics during feed cross-contamination: Animal and human health aspects","volume":"270","author":"Dorne","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/ijms24021696","article-title":"Ionophore toxicity in animals: A review of clinical and molecular aspects","volume":"24","author":"Ekinci","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cvr\/20.2.145","article-title":"Comparison of the effects of the ionophore salinomycin and adrenaline on the haemodynamics and work efficiency of the dog heart","volume":"20","author":"Fahim","year":"1986","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00500018","article-title":"Improvement of cardiac performance by carboxylic ionophore monensin in greyhound and mongrel dogs","volume":"333","author":"Fahim","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"15","key":"10.1016\/j.bj.2026.101057_bib45","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.3390\/molecules27154708","article-title":"Evidence of metallic and polyether ionophores as potent therapeutic drug candidate in cancer management","volume":"27","author":"Pandey","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bj.2026.101057_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41429-022-00571-1","article-title":"Identification of the polyether ionophore lenoremycin through a new screening strategy for targeting cancer stem cells","volume":"75","author":"Ikeda","year":"2022","journal-title":"J Antibiot (Tokyo)"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","article-title":"Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.bj.2026.101057_bib48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41419-023-06262-5","article-title":"mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions","volume":"14","author":"Cosialls","year":"2023","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/med.21870","article-title":"Salinomycin as a potent anticancer stem cell agent: State of the art and future directions","volume":"42","author":"Qi","year":"2022","journal-title":"Med Res Rev"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/acsorginorgau.1c00046","article-title":"Expeditive synthesis of potent C20-epi-amino derivatives of salinomycin against cancer stem-like cells","volume":"2","author":"Czerwonka","year":"2022","journal-title":"ACS Org Inorg Au"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36214-5","article-title":"Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bj.2026.101057_bib53","doi-asserted-by":"crossref","unstructured":"Pressman BC, Painter G, Fahim M. Molecular and biological properties of ionophores. In: Martell AE, editor. Inorganic chemistry in biology and medicine. Washington: American Chemical Society; 1980, p. 3\u201322.","DOI":"10.1021\/bk-1980-0140.ch001"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-6445(03)00019-6","article-title":"Ionophore resistance of ruminal bacteria and its potential impact on human health","volume":"27","author":"Russell","year":"2003","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bj.2026.101057_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-11103-4_6","article-title":"Structural chemistry of natural and synthetic ionophores and their complexes with cations","volume":"101","author":"Hilgenfeld","year":"1982","journal-title":"Top Curr Chem"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/17460440802661443","article-title":"Polyether ionophores: Broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites","volume":"4","author":"Kevin","year":"2009","journal-title":"Expert Opin Drug Discov"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib57","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1074\/jbc.M309658200","article-title":"The linear pentadecapeptide gramicidin is assembled by four multimodular nonribosomal peptide synthetases that comprise 16 modules with 56 catalytic domains","volume":"279","author":"Kessler","year":"2004","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.bj.2026.101057_bib58","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/cbic.202100112","article-title":"Recent advances in bioactive artificial ionophores","volume":"22","author":"Roy","year":"2021","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acs.molpharmaceut.7b00936","article-title":"Metal protein-attenuating compound for pet neuroimaging: Synthesis and preclinical evaluation of [11C]PBT2","volume":"15","author":"Krishnan","year":"2018","journal-title":"Mol Pharm"},{"issue":"23","key":"10.1016\/j.bj.2026.101057_bib60","doi-asserted-by":"crossref","first-page":"17519","DOI":"10.1021\/acs.inorgchem.0c02754","article-title":"Copper(II) binding to PBT2 differs from that of other 8-hydroxyquinoline chelators: Implications for the treatment of neurodegenerative protein misfolding diseases","volume":"59","author":"Summers","year":"2020","journal-title":"Inorg Chem"},{"key":"10.1016\/j.bj.2026.101057_bib61","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-hydroxyquinolines: A review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.bj.2026.101057_bib62","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrmicro.2017.15","article-title":"Metal homeostasis and resistance in bacteria","volume":"15","author":"Chandrangsu","year":"2017","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s44259-026-00233-4","article-title":"Overcoming methicillin resistance in Staphylococcus aureus via metal ion disruption of bacterial metabolism","volume":"4","author":"Macbeth","year":"2026","journal-title":"NPJ Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1203\/PDR.0b013e3181a9eafb","article-title":"Oxygen toxicity and reactive oxygen species: The devil is in the details","volume":"66","author":"Auten","year":"2009","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib65","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s44259-024-00046-3","article-title":"Mechanisms of antimicrobial resistance in biofilms","volume":"2","author":"Liu","year":"2024","journal-title":"NPJ Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00625-23","article-title":"Polyether ionophore antibiotics target drug-resistant clinical isolates, persister cells, and biofilms","volume":"11","author":"Wollesen","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"11","key":"10.1016\/j.bj.2026.101057_bib68","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1128\/AAC.01484-12","article-title":"The urinary antibiotic 5-nitro-8-hydroxyquinoline (nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc","volume":"56","author":"Sobke","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijantimicag.2016.10.017","article-title":"Nitroxoline: A broad-spectrum biofilm-eradicating agent against pathogenic bacteria","volume":"49","author":"Abouelhassan","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.bj.2026.101057_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202501892","article-title":"Antibacterial and antibiofilm activity of 8-hydroxyquinoline derivatives against Mycobacterium and Staphylococcus species","volume":"22","author":"Lall","year":"2025","journal-title":"Chem Biodivers"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/IAI.00858-12","article-title":"Helicobacter pylori stores nickel to aid its host colonization","volume":"81","author":"Benoit","year":"2013","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.bj.2026.101057_bib72","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/IAI.66.11.5060-5066.1998","article-title":"Helicobacter pylori containing only cytoplasmic urease is susceptible to acid","volume":"66","author":"Krishnamurthy","year":"1998","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.bj.2026.101057_bib73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrmicro1994","article-title":"The porin and the permeating antibiotic: A selective diffusion barrier in Gram-negative bacteria","volume":"6","author":"Pages","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.bj.2026.101057_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00433-19","article-title":"Unknown risk on the farm: Does agricultural use of ionophores contribute to the burden of antimicrobial resistance?","volume":"4","author":"Wong","year":"2019","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/antibiotics13020129","article-title":"Is the use of monensin another Trojan Horse for the spread of antimicrobial resistance?","volume":"13","author":"Carresi","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.bj.2026.101057_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03155-23","article-title":"Staphylococcus aureus mutants resistant to the feed-additive monensin show increased virulence and altered purine metabolism","volume":"15","author":"Warsi","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.bj.2026.101057_bib77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fmicb.2020.00104","article-title":"NarAB is an ABC-type transporter that confers resistance to the polyether ionophores narasin, salinomycin, and maduramicin, but not monensin","volume":"11","author":"Naemi","year":"2020","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.bj.2026.101057_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00243-25","article-title":"The ionophore resistance genes narA and narB are geographically widespread and linked to resistance to medically important antibiotics","volume":"10","author":"Ibrahim","year":"2025","journal-title":"mSphere"},{"issue":"10","key":"10.1016\/j.bj.2026.101057_bib79","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.tim.2017.04.010","article-title":"At the nexus of antibiotics and metals: The impact of Cu and Zn on antibiotic activity and resistance","volume":"25","author":"Poole","year":"2017","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib80","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cvfa.2020.07.001","article-title":"Ionophore use and toxicosis in cattle","volume":"36","author":"Ensley","year":"2020","journal-title":"Vet Clin North Am Food Anim Pract"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib81","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3168\/jds.2023-23441","article-title":"Effects of monensin supplementation on rumen fermentation, methane emissions, nitrogen balance, and metabolic responses of dairy cows: A systematic review and dose-response meta-analysis","volume":"107","author":"Rezaei Ahvanooei","year":"2024","journal-title":"J Dairy Sci"},{"issue":"7","key":"10.1016\/j.bj.2026.101057_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.783","article-title":"Dosage-dependent effects of monensin on the rumen microbiota of lactating dairy cattle","volume":"8","author":"McGarvey","year":"2019","journal-title":"Microbiologyopen"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib83","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3168\/jds.2016-11994","article-title":"Differential effects of monensin and a blend of essential oils on rumen microbiota composition of transition dairy cows","volume":"100","author":"Scharen","year":"2017","journal-title":"J Dairy Sci"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40104-023-00967-5","article-title":"Diet and monensin influence the temporal dynamics of the rumen microbiome in stocker and finishing cattle","volume":"15","author":"Chai","year":"2024","journal-title":"J Anim Sci Biotechnol"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib85","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/microorganisms7090282","article-title":"Differential impact of subtherapeutic antibiotics and ionophores on intestinal microbiota of broilers","volume":"7","author":"Robinson","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/jvim.17276","article-title":"Effects of orally administered clioquinol on the fecal microbiome of horses","volume":"39","author":"Smith","year":"2025","journal-title":"J Vet Intern Med"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib87","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-020-06091-y","article-title":"Tools for analysis of the microbiome","volume":"65","author":"Galloway-Pena","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib88","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/acsinfecdis.5c00812","article-title":"Discovery of ionophoroantibiotics as a new antibiotic class targeting metal homeostasis in multidrug-resistant Neisseria gonorrhoeae","volume":"12","author":"Jen","year":"2026","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bj.2026.101057_bib89","doi-asserted-by":"crossref","unstructured":"Casadei BR, Lotierzo MCG, Malheiros B, Barbosa LRS. Drug repurposing and nanoparticles: New strategies against leishmaniasis. In: Formiga FR, Inamuddin, Severino P, editors. Applications of nanobiotechnology for neglected tropical diseases. Amsterdam: Academic Press; 2021, p. 217\u2013241.","DOI":"10.1016\/B978-0-12-821100-7.00007-8"},{"issue":"Suppl_2","key":"10.1016\/j.bj.2026.101057_bib90","doi-asserted-by":"crossref","first-page":"ii11","DOI":"10.1093\/jac\/dkac352","article-title":"Liposomal amphotericin B-the present","volume":"77","author":"Maertens","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13065-023-00980-9","article-title":"Repurposing amphotericin B: Anti-microbial, molecular docking and molecular dynamics simulation studies suggest inhibition potential of amphotericin B against MRSA","volume":"17","author":"Farid","year":"2023","journal-title":"BMC Chem"},{"issue":"10","key":"10.1016\/j.bj.2026.101057_bib92","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.3390\/ijms24108896","article-title":"Repurposing amphotericin B and its liposomal formulation for the treatment of human mpox","volume":"24","author":"Peruzzu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.bj.2026.101057_bib93","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.3390\/ijms22094783","article-title":"Repurposing bedaquiline for effective non-small cell lung cancer (NSCLC) therapy as inhalable cyclodextrin-based molecular inclusion complexes","volume":"22","author":"Parvathaneni","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.bj.2026.101057_bib94","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.18632\/aging.100983","article-title":"Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)","volume":"8","author":"Fiorillo","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.bj.2026.101057_bib95","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clml.2012.05.005","article-title":"A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies","volume":"12","author":"Schimmer","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.bj.2026.101057_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1619416","article-title":"Disulfiram inhibits bacterial growth by inducing zinc-dependent reactive oxygen species","volume":"16","author":"Luo","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bj.2026.101057_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.633194","article-title":"Drug repurposing of the alcohol abuse medication disulfiram as an anti-parasitic agent","volume":"11","author":"Shirley","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.bj.2026.101057_bib98","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-023-02414-4","article-title":"FDA-approved disulfiram as a novel treatment for aggressive leukemia","volume":"102","author":"Karsa","year":"2024","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40659-019-0264-1","article-title":"Gramicidin inhibits human gastric cancer cell proliferation, cell cycle and induced apoptosis","volume":"52","author":"Chen","year":"2019","journal-title":"Biol Res"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12917-019-2026-2","article-title":"Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling","volume":"15","author":"Diao","year":"2019","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib101","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin alpha\/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem J"},{"issue":"10","key":"10.1016\/j.bj.2026.101057_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048456","article-title":"Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells","volume":"7","author":"Pettengill","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bj.2026.101057_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70094","article-title":"Drug repurposing identifies natamycin and avacopan as urease-targeted therapeutic candidates against Helicobacter pylori","volume":"31","author":"Patil","year":"2026","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.bj.2026.101057_bib104","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/biomedicines11030799","article-title":"Repurposing benztropine, natamycin, and nitazoxanide using drug combination and characterization of gastric cancer cell lines","volume":"11","author":"Ribeiro","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bj.2026.101057_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2023.108547","article-title":"Assessing nystatin cream treatment efficacy against Leishmania (l.) amazonensis infection in BALB\/c model","volume":"250","author":"Goncalves-Oliveira","year":"2023","journal-title":"Exp Parasitol"},{"issue":"11","key":"10.1016\/j.bj.2026.101057_bib106","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1021\/acs.jproteome.0c00383","article-title":"In silico drug repurposing for SARS-CoV-2 main proteinase and spike proteins","volume":"19","author":"Maffucci","year":"2020","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.bj.2026.101057_bib107","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/aid.1993.9.475","article-title":"Inhibition of HIV-1 replication in H9 cells by nystatin-a compared with other antiviral agents","volume":"9","author":"Selvam","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.bj.2026.101057_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2026.100646","article-title":"In vitro and in vivo anti-piroplasm activity of PBT2 against Theileria annulata and Babesia microti","volume":"31","author":"Che","year":"2026","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"13","key":"10.1016\/j.bj.2026.101057_bib109","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1021\/acs.jmedchem.4c00261","article-title":"A new Gramicidin S analogue with potent antibacterial activity and negligible hemolytic toxicity","volume":"67","author":"Kalyvas","year":"2024","journal-title":"J Med Chem"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417026001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417026001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:24:47Z","timestamp":1792772687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417026001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":109,"alternative-id":["S2319417026001137"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2026.101057","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Ionophores to Tackle Antimicrobial Resistance with a Focus on PBT2","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2026.101057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"101057"}}